Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Clinical trial NCT06391190 · RECRUITING

Trial details

NCT number: NCT06391190
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cervical Carcinoma Concurrent Chemoradiotherapy Immunotherapy

Start date: 2022-01-01
Primary completion: 2024-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.